Eurocor at CIRSE 2022

We are proud to announce that Eurocor’s 5 year FREEWAY™ safety data will be part of the scientific program (Room 115, Sun. 11th) at CIRSE 2022 conference in Barcelona. We are looking forward to welcoming you at the event, where be present with a booth (#64). Please contact your sales representative to schedule an onsite meeting. Our team will be present from Sept. 10th – 14th.

 

read more

Eurocor at EuroPCR 2022

After a long time of restrictions and online conferences, EuroPCR organization is opening its doors to meet, to learn and exchange expertise in person.

We – at Eurocor Tech – are very happy about this first possibility to meeting you personally again.

We are looking forward to welcoming you at the event. Please contact your sales representative to schedule an onsite meeting.

 

read more

Eurolimus™: award of CE mark and start of commercial sale

Eurocor is proud to announce the CE-marking and commercial launch of Eurolimus™. Eurolimus™ Sirolimus eluting coronary stent system offers great product features to further improve the quality and efficacy stenting procedures. The product features and open-cell desgin with interlinks allowing for high flexibility and overexpansion capabilities while offering one of the lowest strut thicknesses in […]

read more

New Training Module: Cost Effectiveness of DCBs

Discover our new training module on the cost-efficiency of DCB treatment compared to alternative intervention options. You can sign up for a training through your sales representative directly or by reaching out to info@eurocor.de.

read more

FREEWAY™ long lengths (190 & 230 mm) available now!

Discover Eurocor’s new long-length drug coated balloon catheters specifically designed for peripheral intervention of long and challenging lesions.

read more

Eurocor wins Top Poster Award at IROS 2020

Eurocor recieved the TOP Poster award for the presentation of subgroup analysis from the randomized Freeway Stent Study at the 2020 LINC interventional congress in Leipzig, Germany.

read more